Roche Czech Republic invested a total of CZK 114 mil in 2016, down 2.81% compared to the previous year. Historically, between 2003 - 2016, the company's investments stood at a high of CZK 165 mil in 2012 and a low of CZK 77.6 mil in 2011.
As a percentage of total sales, investments stood at 2.30% in 2016, up from 2.16% as seen in the previous year. This is compared to an average of 2.75% over the last five years.
As far as Roche Czech Republic's peers are concerned, Pfizer Czech Republic invested CZK 19.4 mil, or 0.599% of its sales in 2016. Comparable figures for Bayer Czech Republic are CZK 4.92 mil and 0.114%.
You can see all the company’s data at Roche Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
